Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs

Osteoporosis International

Volumn 22, Issue 2, 2011, Pages 693-702

  Allen, M R ^a   Kubek, D J ^a   Burr, D B ^a,b,c   Ruggiero, S L ^e,f   Chu, T M G ^c,d  

^a MS 5035 ^*  (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^e New York Center for Orthognathic and Maxillary Surgery   (United States)

^f STONY BROOK UNIVERSITY   (United States)

Author keywords

Bisphosphonate; Histomorphometry; Mandible; Osteonecrosis; Remodeling

Indexed keywords

ZOLEDRONIC ACID;

ALVEOLAR BONE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; BONE TISSUE; CONTROLLED STUDY; DRUG MEGADOSE; EXPERIMENTAL DOG; FEMALE; JAW OSTEONECROSIS; MANDIBLE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; PREMOLAR TOOTH; PRIORITY JOURNAL; TOOTH EXTRACTION; TOOTH SOCKET; WOUND HEALING;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; CASE-CONTROL STUDIES; DIPHOSPHONATES; DOGS; FEMALE; IMIDAZOLES; JAW DISEASES; OSTEONECROSIS; TOMOGRAPHY, X-RAY COMPUTED; TOOTH EXTRACTION; TREATMENT OUTCOME; WOUND HEALING;

EID: 78651480532     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1268-4     Document Type: Article

References (39)

1. S Khosla D Burr J Cauley DW Dempster PR Ebeling D Felsenberg RF Gagel V Gilsanz T Guise S Koka LK McCauley J McGowan MD McKee S Mohla DG Pendrys LG Raisz SL Ruggiero DM Shafer L Shum SL Silverman CH Van Poznak N Watts SB Woo E Shane 2007 Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 1479 1491 17663640 10.1359/jbmr.0707onj
2. MQ Lacy A Dispenzieri MA Gertz PR Greipp KL Gollbach SR Hayman S Kumar JA Lust SV Rajkumar SJ Russell TE Witzig SR Zeldenrust D Dingli PL Bergsagel R Fonseca CB Reeder AK Stewart V Roy RJ Dalton AB Carr D Kademani EE Keller CF Viozzi RA Kyle 2006 Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma Mayo Clin Proc 81 1047 1053 1:CAS:528:DC%2BD28XoslWku78%3D 16901028 10.4065/81.8.1047
3. SB Woo JW Hellstein JR Kalmar 2006 Systematic review: bisphosphonates and osteonecrosis of the jaws Ann Int Med 144 753 761 1:CAS:528: DC%2BD28XlsFKhs70%3D 16702591
4. T Mavrokokki A Cheng B Stein A Goss 2007 Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in australia J Oral Maxillofac Surg 65 415 423 17307586 10.1016/j.joms.2006.10.061
5. AO Hoff BB Toth K Altundag MM Johnson CL Warneke MM Hu A Nooka G Sayegh V Guarneri K Desrouleaux J Cui A Adamus RF Gagel GN Hortobagyi 2008 Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates J Bone Miner Res 23 826 836 1:CAS:528:DC%2BD1cXnvVGjs70%3D 18558816 10.1359/jbmr.080205
6. RE Marx Y Sawatari M Fortin V Broumand 2005 Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 1567 1575 16243172 10.1016/j.joms.2005.07.010
7. CA Migliorati J Casiglia J Epstein PL Jacobsen MA Siegel SB Woo 2005 Managing the care of patients with bisphosponate-associated osteonecrosis-an American Academy of Oral Medicine position paper J Am Dent Assoc 136 1658 1668 1:CAS:528:DC%2BD28Xks1CktA%3D%3D 16383047
8. K Zervas E Verrou Z Teleioudis K Vahtsevanos A Banti D Mihou D Krikelis E Terpos 2006 Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients Br J Haematol 134 620 623 1:CAS:528:DC%2BD28XhtFSgsLfP 16889620 10.1111/j.1365-2141.2006.06230.x
9. K Vahtsevanos A Kyrgidis E Verrou E Katodritou S Triaridis CG Andreadis I Boukovinas GE Koloutsos Z Teleioudis K Kitikidou P Paraskevopoulos K Zervas K Antoniades 2009 Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw J Clin Oncol 27 32 5356 5362 1:CAS:528:DC%2BD1MXhsFKkt7rF 19805682 10.1200/JCO.2009.21.9584
10. G Cardaropoli M Araujo J Lindhe 2003 Dynamics of bone tissue formation in tooth extraction sites. An experimental study in dogs J Clin Periodontol 30 809 818 1:STN:280:DC%2BD3svnvFyitw%3D%3D 12956657 10.1034/j.1600-051X.2003.00366.x
11. VJ Kingsmill 1999 Post-extraction remodeling of the adult mandible Crit Rev Oral Biol Med 10 384 404 1:STN:280:DC%2BD3c3itFWluw%3D%3D 10759415 10.1177/10454411990100030801
12. MH Amler PL Johnson I Salman 1960 Histological and histochemical investigation of human alveolar socket healing in undisturbed extraction wounds J Am Dent Assoc 61 32 44 1:STN:280:DyaF3c7htlGmtw%3D%3D 13793201
13. MR Allen DB Burr 2009 The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data J Oral Maxillofac Surg 67 61 70 19371816 10.1016/j.joms.2009.01.007
14. SL Ruggiero B Mehrotra 2009 Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management Annu Rev Med 60 85 96 1:CAS:528:DC%2BD1MXitlynt7w%3D 18928335 10.1146/annurev.med.60.063007.134350
15. SL Ruggiero SJ Drew 2007 Osteonecrosis of the jaws and bisphosphonate therapy J Dent Res 86 1013 1021 1:CAS:528:DC%2BD2sXhtleku7rL 17959890 10.1177/154405910708601101
16. SL Ruggiero B Mehrotra TJ Rosenberg SL Engroff 2004 Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 527 534 15122554 10.1016/j.joms.2004.02.004
17. DB Burr 2002 Targeted and nontargeted remodeling Bone 30 2 4 1:STN:280:DC%2BD38%2FmvVWmsg%3D%3D 11792556 10.1016/S8756-3282(01)00619-6
18. E Seeman PD Delmas 2006 Bone quality-the material and structural basis of bone strength and fragility N Engl J Med 354 2250 2261 1:CAS:528: DC%2BD28XkvVShsbw%3D 16723616 10.1056/NEJMra053077
19. MR Allen DB Burr 2008 Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment J Oral Maxillofac Surg 66 987 994 18423290 10.1016/j.joms.2008.01.038
20. DH Enlow 1966 Osteocyte necrosis in normal bone J Dent Res 45 213 1:STN:280:DyaF28%2FotF2nug%3D%3D 4955384 10.1177/00220345660450011901
21. MJ Clemons G Dranitsaris WS Ooi G Yogendran T Sukovic BYL Wong S Verma KI Pritchard M Trudeau DEC Cole 2006 Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy J Clin Oncol 24 4895 4900 1:CAS:528:DC%2BD28Xht1eiu73J 17001071 10.1200/JCO.2006.05.9212
22. MR Allen DJ Kubek DB Burr 2010 Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs J Bone Miner Res 25 98 105 1:CAS:528: DC%2BC3cXksl2ksrw%3D 19580463 10.1359/jbmr.090713
23. J Foldes MS Shih AM Parfitt 1990 Frequency distributions of tetracycline-based measurements: implications for the interpretation of bone formation indices in the absence of double-labeled surfaces J Bone Miner Res 5 1063 1067 1:STN:280:DyaK3M7otFCitQ%3D%3D 2080717 10.1002/jbmr.5650051010
24. AM Parfitt MK Drezner FH Glorieux JA Kanis H Malluche PJ Meunier SM Ott RR Recker 1987 Bone histomorphometry-standardization of nomenclature, symbols, and units J Bone Miner Res 2 595 610 1:STN:280:DyaL1czjvVemsQ%3D%3D 3455637 10.1002/jbmr.5650020617
25. H Hikita K Miyazawa M Tabuchi M Kimura S Goto 2009 Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats J Bone Miner Metab 27 663 672 1:CAS:528: DC%2BD1MXhtlKjtrfF 19436946 10.1007/s00774-009-0090-6
26. H Altundal O Guvener 2004 The effect of alendronate on resorption of the alveolar bone following tooth extraction Int J Oral Maxillofac Surg 33 286 293 1:STN:280:DC%2BD2czotlOlug%3D%3D 15287313 10.1006/ijom.2002.0472
27. J Li S Mori Y Kaji T Mashiba J Kawanishi H Norimatsu 1999 Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats J Bone Miner Res 14 969 979 1:CAS:528:DyaK1MXjvFKqur0%3D 10352106 10.1359/jbmr.1999.14. 6.969
28. MM McDonald S Dulai C Godfrey N Amanat T Sztynda DG Little 2008 Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling Bone 43 4 653 662 1:CAS:528:DC%2BD1cXhtFamsbrK 18582604 10.1016/j.bone.2008.05.019
29. T Hansen M Kunkel E Springer C Walter A Weber E Siegel CJ Kirkpatrick 2007 Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis Virchows Arch 451 1009 1017 17952459 10.1007/s00428-007-0516- 2
30. CL Estilo CH Van Poznak T Wiliams GC Bohle PT Lwin Q Zhou ER Riedel DL Carlson H Schoder A Farooki M Fornier JL Halpern SJ Tunick JM Huryn 2008 Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy Oncologist 13 911 920 18695259 10.1634/theoncologist.2008-0091
31. SL Ruggiero J Fantasia E Carlson 2006 Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 433 441 16997108 10.1016/j.tripleo.2006.06.004
32. ST Sonis BA Watkins GD Lyng MA Lerman KC Anderson 2009 Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients Oral Oncol 45 164 172 1:CAS:528:DC%2BD1MXhtVejurw%3D 18715819 10.1016/j.oraloncology. 2008.04.013
33. JE Gotcher WS Jee 1981 The progress of the periodontal syndrome in the rice rat. II. The effects of a diphosphonate on the periodontium J Periodontal Res 16 441 455 1:CAS:528:DyaL3MXlsVCju78%3D 6459441 10.1111/j.1600-0765.1981. tb00995.x
34. Kikuiri T, Kim I, Yamaza T, Akiyama K, Zhang Q, Li Y, Chen C, Chen W, Wang S, Le AD, Shi S (2010) Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res (in press)
35. FC Senel MK Duman E Muci M Cankaya AA Pampu S Ersoz O Gunhan 2010 Jaw bone changes in rats after treatment with zoledronate and pamidronate Oral Surg Oral Med Oral Pathol Oral Radiol Endo 109 385 391 10.1016/j.tripleo.2009.10.011
36. Y Kobayashi T Hiraga A Ueda L Wang M Matsumoto-Nakano K Hata H Yatani T Yoneda 2010 Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice J Bone Miner Metab 28 165 175 1:CAS:528:DC%2BC3cXisFehu7c%3D 19882100 10.1007/s00774-009-0128-9
37. M Biasotto S Chiandussi S Zacchigna S Moimas F Dore G Pozzato F Cavalli F Zanconati L Contardo M Giacca R Di Lenarda 2010 A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw J Oral Pathol Med 35 5 390 396
38. Hokugo A, Christensen R, Chung E, Sung E, Felsenfeld AL, Sayre JW, Garrett N, Adams JS, Nishimura I (2010) Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. J Bone Miner Res. doi: 10.1002/jbmr.23
39. FC Senel MK Duman E Muci M Cankaya AA Pampu S Ersoz O Gunhan 2010 Jaw bone changes in rats after treatment with zoledronate and pamidronate Oral Surg Oral Med Oral Pathol Oral Radiol Endo 109 3 385 391 10.1016/j.tripleo.2009.10. 011